Arialys Therapeutics Targets First in Class Precision Therapy for Autoimmune Encephalitis
ART5803 targets NMDA receptor autoantibodies, advancing precision therapy for autoimmune encephalitis.
Read More
Month: June 2025
Strategic Industry Context: Alzheimer’s Drug Reimbursement Faces Global Pressure
NICE deems donanemab and lecanemab not cost-effective, blocks NHS coverage for Alzheimer’s drugs.
Read MoreENHERTU Advances First-Line Endometrial Therapy in Phase 3 Trial
ENHERTU Phase 3 trial launches for first-line endometrial therapy targeting HER2-expressing tumors.
Read More
Alexion Strikes Bold AI Partnership for Rare Disease Detection
AI partnership targets rare bone disease affecting 1 in 6,000 patients.
Read More
ZEISS CLARUS 700 Gains China NMPA Approval for Retinal Imaging
ZEISS expands retinal diagnostic capabilities in China with CLARUS 700 ultra-widefield imaging system approval.
Read More